Nasdaq panel grants Movano Health listing extension through Oct 30, 2025

Corvex, Inc.

Deadline to file delinquent Q1 and Q2 2025 10-Qs is Sept 30, 2025; bid price compliance by Oct 30, 2025.
Preliminary proxy filed for annual meeting on Sept 26, 2025, seeking reverse stock split approval.
Company working with new auditor to complete the overdue quarterly reports.
Panel hearing held Aug 19, 2025; extension letter received Aug 27, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.